Banner

Coronary artery bypass grafting versus concomitant mitral valve annuloplasty in moderate ischemic mitral regurgitation: 4-year follow-up

• 2016
العودة
معلومات البحث
المؤلفون Tamer Hamdy Hamouda1,2 & Mohamed Fouad Ismail1,3 & Ahmed Farid El-Mahrouk1,4 & Ahmed Abdullah Jamjoom1 & Hanan Ibrahim Radwan1,5 & Abdelhakem Selem Alsayd Selem
الكلمات المفتاحية Mitral valve . Mitral valve annuloplasty . Moderate ischemic mitral regurgitation
المجلة العلمية Not Available
الناشر Not Available
المجلد Not Available
العدد Not Available
الصفحات Not Available
publication.type International
رابط البحث Not Available
المواد المرفقة Not Available
الملخص
Objective In severe ischemic mitral regurgitation (IMR), there
is benefit evidence for mitral valve repair with coronary artery
bypass grafting (CABG). However, there is still a debate
around combined repair and CABG for moderate IMR. We
evaluate our results over 4-year follow-up for patients with
moderate IMR who underwent isolated CABG and combined
with mitral ring annuloplasty.
Methods We retrospectively studied patients with moderate
IMR; 69 patients underwent CABG alone group (A), and 77
patients underwent CABG with mitral valve ring annuloplasty
group (B). New York Heart Association functional class
(NYHA class), mitral regurgitation (MR) grade, and left ventricle
(LV) dimension and ejection fraction (EF) were assessed
preoperatively, 1 and 4 years postoperatively.
Results The mortality rate was 2.9% in group (A) and 1.8% in
group (B) p = 0.1593. Improvement in NYHA class, MR, and
LVEF % were significant in both groups at 1 year with no significant
changes at 4 years. However, group (B) showed
significant improvement in LVEF % than group (A) at 4 years
(47.5 ± 7.3 vs 44 ± 1.7, p 0.0001). It showed improvement in
NYHA class at 1 and 4 years (1.5 ± 0.4 vs 2.1 ± 0.2) and (1 ± 0.2
vs 1.5 ± 0.5) p 0.0001, respectively. After 4 years, group (A)
showed deterioration of MR degree in 4.3% of patients.
Conclusion We strongly advise to add mitral valve ring
annuloplasty with CABG for patients with moderate IMR.